http://rdf.ncbi.nlm.nih.gov/pubchem/reference/265171

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Journal Article
endingPage 134
issn 0277-3732
issueIdentifier 2
pageRange 132-134
publicationName American Journal of Clinical Oncology
startingPage 132
bibliographicCitation Nasta SD, Hoff PM, George CS, Neubauer M, Cohen SC, Abbruzzese J, Winn R, Pazdur RM. Phase II Study of MGI-114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer. American Journal of Clinical Oncology. 2003 Apr;26(2):132–4. doi: 10.1097/01.coc.0000017092.65803.76.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1d92ba270087d944f032bbfbffeb9cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_019d7ee2172718130448eb38ac9af88a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d022bb14550760b9e32db6444fa2926b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f86e3e933a877740b3bb8184278a22f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f3bfdfa6875b172dc0a3889dfdb3be9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08545cc2c216dfe28240e1acd1258446
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_307a7b84da161511ebecf1e2726da0ba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee21ca59a68740d075a001971e3fc3d8
date 200304
identifier https://doi.org/10.1097/01.coc.0000017092.65803.76
https://doi.org/10.1097/00000421-200304000-00006
https://pubmed.ncbi.nlm.nih.gov/12714882
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/413
https://portal.issn.org/resource/ISSN/0277-3732
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Phase II Study of MGI-114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer
discusses http://id.nlm.nih.gov/mesh/M0019703
http://id.nlm.nih.gov/mesh/M0268775
http://id.nlm.nih.gov/mesh/M0028268
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D012717Q000627
http://id.nlm.nih.gov/mesh/D018906Q000627
http://id.nlm.nih.gov/mesh/D015179Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D009362
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D007262
http://id.nlm.nih.gov/mesh/D015179Q000473
http://id.nlm.nih.gov/mesh/D004334
http://id.nlm.nih.gov/mesh/D012717Q000008
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D016019
http://id.nlm.nih.gov/mesh/D018906Q000008
http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8177
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7893
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148189
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6923

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135844626

Total number of triples: 56.